PREDILIFE
AI-driven predictive tests assessing cancer and cardiovascular disease risks for partners.
ALPRE | PA
Overview
Corporate Details
- ISIN(s):
- FR0010169920 (+5 more)
- LEI:
- 9695006IK5NBKHQU9116
- Country:
- France
- Address:
- 39 RUE CAMILLE DESMOULINS, 94800 VILLEJUIF
- Website:
- https://www.predilife.com/en/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
PREDILIFE is a medical technology company specializing in predictive medicine. Founded in 2004, the company designs and markets predictive tests that assess an individual's risk of developing serious diseases. By combining artificial intelligence and big data with proven medical technologies, PREDILIFE creates personalized risk profiles. Its primary services include the Predictive Check-Up for Breast Cancer (MammoRisk®) and a comprehensive Predictive Check-Up for Multiple Conditions, which covers various cancers (lung, prostate, colorectal, melanoma) and cardiovascular disease. The company provides an end-to-end, digital solution for businesses, insurance companies, and healthcare professionals, aiming to make personalized, preventive care more accessible and affordable.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-24 18:30 |
Report Publication Announcement
Predilife met à disposition son rapport financier semestriel 2025
|
French | 358.5 KB | ||
| 2025-10-09 18:30 |
Earnings Release
PREDILIFE : Résultats semestriels 2025 - Multiplication du chiffre d'affaires p…
|
French | 731.9 KB | ||
| 2025-07-22 19:00 |
Capital/Financing Update
PREDILIFE ANNONCE LA RÉALISATION D'UN PLACEMENT PRIVE DE 300 K EUR PERMETTANT D…
|
French | 498.0 KB | ||
| 2025-06-11 19:00 |
Capital/Financing Update
Avenant au contrat de liquidité conclu avec TSAF
|
French | 164.0 KB | ||
| 2025-06-06 20:15 |
Report Publication Announcement
Mise à disposition du rapport financier annuel 2024
|
French | 383.3 KB | ||
| 2025-05-15 08:00 |
Earnings Release
RÉSULTATS ANNUELS 2024 - PERSPECTIVES DE CROISSANCE ET DE PARTENARIAT 2025
|
French | 283.1 KB | ||
| 2025-04-30 18:30 |
Report Publication Announcement
REPORT DE LA PUBLICATION DES RESULTATS ANNUELS 2024 ET DU RAPPORT FINANCIER ANN…
|
French | 162.4 KB | ||
| 2025-01-17 18:00 |
Regulatory Filings
Bilan semestriel au 31/12/2024 du contrat de liquidité PREDILIFE
|
French | 417.3 KB | ||
| 2025-01-08 18:30 |
Earnings Release
PREDILIFE DOUBLE SON VOLUME DE VENTE EN 2024 ET ANTICIPE UNE FORTE CROISSANCE P…
|
French | 248.6 KB | ||
| 2024-12-17 20:00 |
Capital/Financing Update
PREDILIFE ANNONCE LA RÉALISATION D'UNE LEVÉE DE FONDS DE 779 000 EUROS DANS LE …
|
French | 396.7 KB | ||
| 2024-11-12 08:30 |
Capital/Financing Update
Predilife lance une émission d'obligations de 2M EUR à un taux de 8,5% par an s…
|
French | 898.9 KB | ||
| 2024-11-07 18:30 |
M&A Activity
Réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 …
|
French | 225.6 KB | ||
| 2024-10-30 19:00 |
Report Publication Announcement
Predilife met à disposition son rapport financier semestriel 2024
|
French | 158.4 KB | ||
| 2024-10-28 08:30 |
Earnings Release
Résultats semestriels 2024 - Perspectives de croissance 2024
|
French | 256.4 KB | ||
| 2024-10-21 18:30 |
Environmental & Social Information
Le Groupe Rocher prend une initiative majeure pour la santé des femmes et propo…
|
French | 236.4 KB |
Automate Your Workflow. Get a real-time feed of all PREDILIFE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PREDILIFE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PREDILIFE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-30 | N/A | Other | Buy | 200 | 960.00 EUR |
| 2024-07-04 | N/A | Other | Buy | 400 | 2,720.00 EUR |
| 2024-06-26 | N/A | Other | Buy | 2,000 | 12,000.00 EUR |
| 2024-06-18 | N/A | Other | Buy | 500 | 2,800.00 EUR |
| 2024-05-02 | N/A | Other | Sell | 8,500 | 204,000.00 EUR |
| 2024-04-26 | N/A | Other | Buy | 599 | 2,635.60 EUR |
| 2024-02-28 | N/A | Other | Buy | 1,600 | 6,720.00 EUR |
| 2024-02-26 | N/A | Other | Buy | 500 | 2,150.00 EUR |
| 2024-02-22 | N/A | Other | Buy | 500 | 2,250.00 EUR |
| 2024-02-20 | N/A | Other | Other | 1,000 | 4,800.00 EUR |
Peer Companies
